Skip to main content
Download PDF

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Breast Cancer Research volume 24, Article number: 50 (2022) Cite this article

The Original Article was published on 18 August 2020

Correction to: Breast Cancer Research (2020) 22:91 https://doi.org/10.1186/s13058-020-01328-0

Following publication of the original article [1], the authors identified some errors in Fig. 4. The correct figure is given below.

Fig. 4
figure 4

Prognostic associations in this cohort of sequenced metastatic breast cancer patients. a Overall survival by subtype for all recruited patients (n = 323). b Overall survival of patients based on the mutational burden of 4 mutations (75th percentile) or more (n = 234). c Overall survival of ER + HER2 − patients based on the median mutation number of 4 or more (n = 163 patients). d Table of HR for all patients and all subtypes by mutation number per sample. Patients were excluded if there was incomplete survival information. e Spread of TILs across distant metastatic site (n = 123)

Full size image

The original article [1] has been corrected.

Reference

  1. van Geelen CT, Savas P, Teo ZL, Luen SJ, Weng C-F, Ko Y-A, Kuykhoven KS, Caramia F, Salgado R, Francis PA, Dawson S-J, Fox SB, Fellowes A, Loi S. Clinical implications of prospective genomic profiling of metastatic breast cancer patients. Breast Cancer Res. 2020;22:91. https://doi.org/10.1186/s13058-020-01328-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Courtney van Geelen and Peter Savas are co-first authors.

Authors and Affiliations

  1. Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia

    Courtney T. van Geelen, Peter Savas, Zhi Ling Teo, Stephen J. Luen, Chen-Fang Weng, Yi-An Ko, Franco Caramia, Roberto Salgado, Sarah-Jane Dawson, Stephen B. Fox & Sherene Loi

  2. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

    Peter Savas, Stephen J. Luen, Prudence A. Francis, Sarah-Jane Dawson & Sherene Loi

  3. Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity, Geelong, Australia

    Keilly S. Kuykhoven

  4. Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia

    Stephen B. Fox & Andrew Fellowes

  5. Sir Peter MacCallum Department of Oncology, University of Melbourne, 305 Grattan St, Melbourne, VIC, 3000, Australia

    Prudence A. Francis, Sarah-Jane Dawson, Stephen B. Fox & Sherene Loi

Authors
  1. Courtney T. van Geelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Savas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhi Ling Teo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephen J. Luen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chen-Fang Weng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi-An Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keilly S. Kuykhoven
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Franco Caramia
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Roberto Salgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Prudence A. Francis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sarah-Jane Dawson
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Stephen B. Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Andrew Fellowes
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Sherene Loi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sherene Loi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van Geelen, C.T., Savas, P., Teo, Z.L. et al. Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients. Breast Cancer Res 24, 50 (2022). https://doi.org/10.1186/s13058-022-01539-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13058-022-01539-7

Breast Cancer Research

ISSN: 1465-542X

Contact us